TWO SIGMA INVESTMENTS, LP - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$218,624
-40.2%
24,400
-24.9%
0.00%0.0%
Q2 2023$365,625
-80.0%
32,500
-79.6%
0.00%
-80.0%
Q1 2023$1,831,530
+1.7%
158,987
+2.3%
0.01%
-16.7%
Q4 2022$1,800,495
+733.6%
155,349
+812.5%
0.01%
+500.0%
Q3 2022$216,000
-16.3%
17,024
-36.3%
0.00%0.0%
Q1 2022$258,000
-83.0%
26,722
-79.1%
0.00%
-66.7%
Q4 2021$1,519,000
-17.4%
127,729
+12.8%
0.00%
-25.0%
Q3 2021$1,838,000
+355.0%
113,204
+335.4%
0.00%
+300.0%
Q1 2021$404,00026,0000.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders